Anesthetic Management of Diabetes in Perioperative Urology and Visceral Surgery

Completed

• Conditions: Diabetes Mellitus

• Registration Number: NCT06553170
• Lead Sponsor: University Hospital, Brest

Brief Summary

It is recognized that a poor glycemic, pre- and intraoperative balance is the source of increase in morbimortality. There was no local protocol at the CHRU Brest regarding the perioperative management of the diabetic patient. This retrospective observational work aims to assess the application of the French recommendations for the perioperative management of diabetes, and compare management before and after the introduction of a protocol based on its recommendations published in 2017 by the SFAR.

The main endpoint is the percentage of patients for whom half of the patients recommendations from the local protocol were implemented for each of the recommendations evaluated and applicable to each patient, before and after protocol and staff training.

Detailed Description

Half of the recommandations are implemented for each recommendation evaluated applicable in 29% of patients(n=25) in the before group versus 66.23% (n=52) in the after group (p\<0.05).

This corresponds to an improvement significant of 36.23% for our primary endpoint.

Study Timeline

• Study Start: 2017-12-01
• Status Verified: 2019-09
• Primary Completion: 2019-09-01
• Study Completion: 2019-09-01
• Study First Submitted: 2021-06-10
• Study First Submitted QC: 2024-08-12
• Last Update Submitted: 2024-08-12
• Study First Posted: 2024-08-14
• Last Update Posted: 2024-08-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 196

Inclusion Criteria

• patients diabetics
• urology or visceral surgery

Exclusion Criteria

• ambulatory surgery

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
follow the recommendations	1 year after	The main endpoint is the percentage of patients for whom half of patients recommendations of the local protocol were implemented for each of the recommendations evaluated and applicable to each patient, before and after the application of the protocol and training staff.

Secondary Outcome Measures

Name	Time	Method
complications and mortality	1 year after	Secondary endpoints are hospital mortality, the occurrence of early postoperative complications related to diabetes, the occurrence of complications post-operative surgery, and finally the occurrence of medical complications not related to Diabetes.

Trial Locations

Locations (1)

Cadic; 🇫🇷 Brest, Bretagne, France